INVO Fertility, Inc.

INVO Fertility, Inc. is a healthcare services and technology company focused on the fertility marketplace, dedicated to expanding access to assisted reproductive technology ("ART") care. The company's principal commercial strategy involves acquiring, establishing, and operating fertility clinics and related businesses and technologies. Its acquisition strategy targets US-based, profitable fertility clinics. INVO Fertility's clinics provide a variety of fertility services, including in vitro fertilization ("IVF") and the intravaginal culture ("IVC") procedure, which is enabled by its INVOcell® medical device ("INVOcell"). As of the date of this filing, INVO Fertility operates four fertility clinics in the United States. The company also sells and distributes its INVOcell technology solution to third-party owned and operated fertility clinics. Additionally, INVO Fertility plans to seek out and license or acquire additional, innovative fertility-focused technologies for use within its clinics. On February 18, 2026, the company completed the acquisition of Family Beginnings, an Indiana-based fertility clinic that offers both IVF and IVC. All information is as of December 31, 2025, unless otherwise indicated.